Clinical Trial Update: Cytokine Induced Killer Cells Stimulated by DC Immunotherapy for Renal Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial is investigating cytokine-induced killer (CIK) cells stimulated by dendritic cell immunotherapy in patients with renal cell car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Cytokine Induced Killer Cells Stimulated by Dendritic Cell Immunotherapy

Snippet

Sponsor: Qingdao University | Conditions: Renal Cell Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN